The webinar covers:

  • the HPV vaccine and its impact in Australia and globally
  • a roadmap for cervical cancer elimination in Australia and our region
  • changes to the Australian HPV vaccination schedule and their implications
  • initiatives designed to maintain high levels of HPV vaccine coverage.

Presentation recordings:

  • HPV vaccine: where are we now? — Professor Julia Brotherton

    Portrait of Professor Julia BrothertonProfessor Julia Brotherton
    Professor, Cancer Prevention Policy and Implementation – Melbourne School of Population and Global Health

    Professor Julia Brotherton is a public health physician, epidemiologist and Professor of Cancer Prevention Policy and Implementation at the Melbourne School of Population and Global Health at the University of Melbourne. She is also a Professorial Fellow at NCIRS. 

    For over 15 years, Julia has been involved in research and policy development informing the implementation and evaluation of HPV vaccination and cervical screening programs. She is a member of the WHO Director General’s Expert Advisory Group on Cervical Cancer Elimination and of the Coalition to Strengthen the HPV Immunization Community (CHIC) global HPV Vaccine Council, as well as a CI on both the National Health and Medical Research Council (NHMRC) Centre of Research Excellence (CRE) in Cervical Cancer Control and the NHMRC CRE in Targeted Approaches to Improve Cancer Services for Aboriginal and Torres Strait Islander Australians.

  • Cervical cancer elimination modelling and work to support countries in the region — Dr Kate Simms

    Image: A portrait of Dr Kate SimmsDr Kate Simms
    Senior Research Fellow – Daffodil Centre

    Dr Kate Simms leads the team on cervical cancer prevention in low and middle-income countries at the Daffodil Centre. Her research focuses on modelling the impact of HPV vaccination and cervical screening in these settings. 

    She has been involved in modelled evaluations across a range of settings, including in Australia, New Zealand, England, the United States, Japan, China, Papua New Guinea and Malaysia, as well as for the WHO. Her modelling work has directly supported the renewal of the Australian National Cervical Screening Program, the WHO strategy for cervical cancer elimination and WHO’s updated cervical screening guidelines.

  • Changes to the HPV vaccine schedule in Australia — Professor Michelle Giles (presented by Professor Kristine Macartney)

    Image: A portrait of Professor Michelle GilesProfessor Michelle Giles
    Professor, Department of Obstetrics & Gynaecology – Monash University

    Professor Giles is an infectious diseases physician who specialises in infections in pregnancy and maternal immunisation. Her clinical research focus is on maternal immunisation and bloodborne viruses in pregnancy such as HIV, hepatitis B and hepatitis C.
    Michelle is co-lead of the Clinical and Health Systems Research cross-cutting discipline at the Doherty Institute. She holds clinical appointments at Alfred Health, The Royal Women’s Hospital, Monash Health and Western Health, as well as academic appointments at the Department of Infectious Diseases at the University of Melbourne and the Department of Obstetrics and Gynaecology at Monash University.
    During the COVID-19 pandemic, Michelle supported the government’s response through a focus on control of community transmission of infection and by leading policy advice for the COVID-19 vaccination program.

    Image: A portrait of Professor Kristine MacartneyProfessor Kristine Macartney 
    Director – NCIRS

    Kristine Macartney is a paediatrician, infectious disease specialist and vaccinologist. She previously worked in the US, at the Children’s Hospital of Philadelphia, and she was a founding member of the US Vaccine Education Center.

    Kristine’s particular interests include the translation of evidence into policy and practice; vaccine safety; and vaccine-preventable diseases research – particularly in viral diseases, including COVID-19, rotavirus, varicella zoster virus, human papillomavirus (HPV) and influenza. She is the senior editor of the Australian Immunisation Handbook, has authored more than 200 peer-reviewed publications and is a member of key peak advisory committees in Australia, including the Australian Technical Advisory Group on Immunisation (ATAGI).

    Kristine is also an expert consultant to the World Health Organization (WHO), a member of the WHO Global Advisory Committee on Vaccine Safety, a member of WHO-SAGE subcommittees and the Founding Chair of the Australian Regional Immunisation Alliance. She has a clinical appointment at The Children’s Hospital at Westmead as a Staff Specialist in Infectious Diseases and Microbiology and a conjoint academic appointment as Professor in the Discipline of Child and Adolescent Health at the University of Sydney.

  • NSW Transition to a One Dose HPV Schedule — Sarah Hynes

    Image: A portrait of Sarah HynesSarah Hynes
    Senior Project Officer – Health Protection NSW

    Sarah is a Senior Project Officer in the Immunisation Branch of Health Protection NSW. She is an authorised immunisation nurse who oversees the NSW school vaccination program in the Ministry of Health. Her background is in public health throughout both NSW and Qld.

  • Q&A session

    Image: A portrait of Dr Ketaki SharmaDr Ketaki Sharma
    Staff Specialist, Immunisation – NCIRS 

    Ketaki Sharma is a general paediatrician and staff specialist at NCIRS. She holds a conjoint appointment as Clinical Lecturer in the Discipline of Child and Adolescent Health at the University of Sydney. Ketaki is a member of the NCIRS team that provides scientific and technical support to ATAGI. She is also part of the New South Wales Immunisation Specialist Service. 

    Ketaki is undertaking research on optimising vaccination during pregnancy to protect newborn infants from vaccine-preventable illnesses. She also has a special interest in vaccination of people with immunocompromise.

  • Additional resources